UPDATE: Citi Upgrades Emerson (EMR) to Neutral
Tweet
Share
E-mail
Get Alerts EMR Hot Sheet
Price: $158.88 -1.96%
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Join SI Premium – FREE
(Updated - January 14, 2019 9:41 AM EST)
(updated to correct rating action)
Citi analyst Andrew Kaplowitz upgraded Emerson (NYSE: EMR) from Sell to Neutral with a price target of $66.00 (from $69.00).
For an analyst ratings summary and ratings history on Emerson click here. For more ratings news on Emerson click here.
Shares of Emerson closed at $62.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades Bath & Body Works to Buy with $25 price target
- Pony AI Inc (PONY) PT Lowered to $17 at BofA Securities
- JPMorgan Upgrades CITIC Securities Company Limited (6030:HK) (CIIHY) to Overweight
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
